Elizabeth Crowley
- Oncology top 5%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 5%
- Pulmonary and Respiratory Medicine top 10%
- Immunology
- Co-authors
- Thomas HawthorneThomas A. DavisRonit SimantovLinda T. VahdatUlrik LassenMansoor N. SalehJennifer GreenTheodore S. Hong
- Topics
- HER2/EGFR in Cancer Research (10 papers)Monoclonal and Polyclonal Antibodies Research (8 papers)Advanced Radiotherapy Techniques (6 papers)
- Partner nations
- United StatesGermanyDenmark
In The Last Decade
Elizabeth Crowley
39 papers receiving 977 citations
Peers
Comparison fields: 5 of 71
- Oncology 473
- Molecular Biology 255
- Radiology, Nuclear Medicine and Imaging 244
- Pulmonary and Respiratory Medicine 242
- Immunology 172
Countries citing papers authored by Elizabeth Crowley
This map shows the geographic impact of Elizabeth Crowley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Crowley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Crowley more than expected).
Fields of papers citing papers by Elizabeth Crowley
This network shows the impact of papers produced by Elizabeth Crowley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Crowley. The network helps show where Elizabeth Crowley may publish in the future.
Co-authorship network of co-authors of Elizabeth Crowley
This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Crowley. A scholar is included among the top collaborators of Elizabeth Crowley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Crowley. Elizabeth Crowley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 3 | |
| 3 | 5 | |
| 4 | 62 | |
| 5 | 81 | |
| 6 | 52 | |
| 7 | 145 | |
| 8 | 3 | |
| 9 | 42 | |
| 10 | 3 | |
| 11 | 66 | |
| 12 | 20 | |
| 13 | 2 | |
| 14 | 13 | |
| 15 | 72 | |
| 16 | 20 | |
| 17 | A phase I study of oral belinostat (PXD101) in patients with advanced solid tumors. | 2 |
| 18 | 35 | |
| 19 | 48 | |
| 20 | 21 |
About Elizabeth Crowley
Elizabeth Crowley is a scholar working on Oncology, Radiation and Immunology and Allergy, having authored 39 papers that have together received 1.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Advanced Radiotherapy Techniques (6 papers). The work is most often cited by research in Oncology (473 citations), Radiation (103 citations) and Radiology, Nuclear Medicine and Imaging (244 citations). Elizabeth Crowley has collaborated with scholars based in United States, Germany and Denmark. Frequent co-authors include Thomas Hawthorne, Thomas A. Davis, Ronit Simantov, Linda T. Vahdat, Ulrik Lassen, Mansoor N. Saleh, Jennifer Green, Theodore S. Hong, Richard T. Penson and Margo Heath‐Chiozzi. Their work appears in journals such as Journal of Clinical Oncology, Blood and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.